Eureka Forbes Ltd

Eureka Forbes Summary Chart Analysis Peers Quarters Profit & Loss Balance Sheet Cash Flow Ratios Investors Documents

Eureka Forbes Ltd

₹ 579 3.38%
16 Sep - close price
eurekaforbes.com BSE: 543482 NSE: EUREKAFORB
About

Eureka Forbes Limited (EFL) is a part of the private equity firm advent which was bought from Shapoorjipallonji group company forbes LTD . Company is engaged in the health & hygiene segment with product profiles comprising water purifiers, vacuum cleaners, air purifiers, and home security systems.[1]

Key Points

Flagship Products[1]
Aquaguard is the award-winning water purifier brand of Eureka Forbes. The Forbes vacuum cleaners are market leaders of the company and remain as #1 vacuum cleaner brand in 2020-21. Other products under the Eureka Forbes umbrella include Dr. Aeroguard, Forbes Health Conditioner, and Air purifiers.

Website BSE NSE
  • Market Cap ₹ 11,237 Cr.
  • Current Price ₹ 579
  • High / Low ₹ 656 / 452
  • Stock P/E 67.3
  • Book Value ₹ 227
  • Dividend Yield 0.00 %
  • ROCE 5.04 %
  • ROE 3.69 %
  • Face Value ₹ 10.0
Edit ratios

Pros

  • Company has reduced debt.
  • Company is almost debt free.
  • Company has delivered good profit growth of 183% CAGR over last 5 years

Cons

  • Stock is trading at 2.56 times its book value
  • Though the company is reporting repeated profits, it is not paying out dividend
  • Company has a low return on equity of 2.30% over last 3 years.
  • Promoters have pledged or encumbered 53.7% of their holding.
  • Promoter holding has decreased over last 3 years: -10.8%

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Peer comparison

Consumer Discretionary Consumer Durables Consumer Durables Household Appliances

Part of Nifty Microcap 250 Nifty Total Market

Edit Columns
Loading peers table ...

Quarterly Results

Standalone Figures in Rs. Crores / View Consolidated

Jun 2022 Sep 2022 Dec 2022 Mar 2023 Jun 2023 Sep 2023 Dec 2023 Mar 2024 Jun 2024 Sep 2024 Dec 2024 Mar 2025 Jun 2025
525 575 472 508 505 592 539 553 553 673 598 613 608
482 575 431 461 459 541 496 500 498 601 539 535 546
Operating Profit 43 0 41 47 46 51 42 53 55 72 59 78 61
OPM % 8% 0% 9% 9% 9% 9% 8% 10% 10% 11% 10% 13% 10%
1 -15 -10 -5 2 2 3 -13 2 6 4 6 7
Interest 6 6 4 3 3 3 2 2 2 2 1 1 1
Depreciation 13 16 13 13 13 13 13 14 14 14 15 15 16
Profit before tax 24 -36 13 26 31 37 30 24 42 62 47 68 52
Tax % 27% -26% 25% 37% 29% 31% 25% 12% 25% 25% 26% 25% 25%
18 -27 10 16 22 25 23 21 31 47 35 51 39
EPS in Rs 0.92 -1.39 0.51 0.84 1.14 1.32 1.17 1.11 1.61 2.41 1.80 2.62 1.99
Raw PDF

Profit & Loss

Standalone Figures in Rs. Crores / View Consolidated

Mar 2013 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 TTM
0 0 28 33 27 26 16 8 381 2,080 2,189 2,436 2,491
0 0 28 32 27 26 16 9 363 1,949 1,997 2,173 2,222
Operating Profit 0 0 1 2 -1 -0 -0 -1 18 132 192 263 269
OPM % 2% 5% -3% -1% -0% -17% 5% 6% 9% 11% 11%
0 0 0 -0 0 0 0 0 2 -30 -7 19 24
Interest 0 0 0 1 0 0 0 0 4 20 10 6 5
Depreciation 0 0 0 0 0 0 0 0 9 55 53 58 60
Profit before tax 0 0 0 1 -1 -1 -1 -2 7 27 122 219 229
Tax % -8% 8% 9% -9% 56% 1% 59% 37% 25% 25%
0 0 0 1 -1 -1 -1 -2 3 17 92 163 171
EPS in Rs 0.00 0.00 0.50 2.62 -4.70 -2.48 -1.84 -3.38 0.14 0.88 4.73 8.44 8.82
Dividend Payout % 0% 0% 0% 0% 0% 0% 0% 0% 0% 0%
Compounded Sales Growth
10 Years: %
5 Years: 172%
3 Years: 86%
TTM: 11%
Compounded Profit Growth
10 Years: %
5 Years: 183%
3 Years: 294%
TTM: 50%
Stock Price CAGR
10 Years: %
5 Years: %
3 Years: 5%
1 Year: 8%
Return on Equity
10 Years: 2%
5 Years: 2%
3 Years: 2%
Last Year: 4%

Balance Sheet

Standalone Figures in Rs. Crores / View Consolidated

Mar 2013 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Equity Capital 0.05 0.05 3 3 3 3 5 5 193 193 193 193
Reserves -0 -0 -1 -0 -2 -2 -3 -5 3,874 3,886 4,010 4,191
0 0 4 4 4 4 2 2 253 139 39 26
0 0 12 12 9 9 7 5 1,815 1,810 1,878 1,899
Total Liabilities 0 0 18 18 14 14 10 7 6,135 6,029 6,120 6,310
0 0 1 0 0 0 0 0 5,498 5,475 5,457 5,466
CWIP 0 0 0 0 0 0 0 0 0 2 1 2
Investments 0 0 0 0 0 0 0 0 87 101 80 84
0 0 17 18 14 14 10 7 550 451 582 758
Total Assets 0 0 18 18 14 14 10 7 6,135 6,029 6,120 6,310

Cash Flows

Standalone Figures in Rs. Crores / View Consolidated

Mar 2013 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
1 0 37 171 195 226
0 0 7 -22 -35 -168
-1 -0 -31 -150 -117 -43
Net Cash Flow -1 -0 13 -1 43 14

Ratios

Standalone Figures in Rs. Crores / View Consolidated

Mar 2013 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Debtor Days 156 141 107 110 63 110 147 22 23 27
Inventory Days 34 21 37 33 90 109 638 91 99 87
Days Payable 164 153 137 143 159 256 549 99 89 67
Cash Conversion Cycle 26 10 7 1 -7 -37 235 14 33 47
Working Capital Days 37 34 31 -48 -33 -105 -546 -103 -87 -71
ROCE % 0% 20% 24% -12% -5% -4% -58% 0% 2% 3% 5%

Shareholding Pattern

Numbers in percentages

2 Recently
Sep 2022Dec 2022Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025
73.23% 73.23% 72.56% 72.56% 72.56% 72.56% 62.56% 62.56% 62.56% 62.56% 62.56% 62.56%
11.55% 11.54% 10.94% 10.76% 10.61% 10.76% 16.01% 13.21% 12.62% 12.56% 12.53% 14.00%
1.22% 1.48% 1.87% 2.73% 3.45% 4.00% 5.64% 6.30% 6.67% 6.60% 7.01% 6.35%
0.86% 0.86% 0.86% 0.86% 0.86% 0.86% 0.86% 0.86% 0.86% 0.86% 0.86% 0.86%
13.15% 12.90% 13.79% 13.10% 12.53% 11.83% 14.93% 17.08% 17.29% 17.41% 17.03% 16.23%
No. of Shareholders 14,76114,36914,11814,83615,83821,84326,75128,11531,62832,45330,68329,638

* The classifications might have changed from Sep'2022 onwards. The new XBRL format added more details from Sep'22 onwards.

Classifications such as banks and foreign portfolio investors were not available earlier. The sudden changes in FII or DII can be because of these changes.

Click on the line-items to see the names of individual entities.

Documents

Announcements

Annual reports

Credit ratings

Concalls